Clécio Fernando Klitzke

Clécio Fernando Klitzke

Auto-generated profile, based on publicly available information

Clécio Fernando Klitzke

GCTOF Analytical Solution Balneario Camboriu SC Brazil

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2011 in Analytical Chemistry
Verified
Journal Article
Closed access
VSVanessa G. Santos
Vanessa G. Santos
TCThais Regiani Cataldi
Thais Regiani Cataldi
Fernanda F G DiasFernanda F G Dias
Fernanda F G Dias
WRWanderson Romão
Wanderson Romão
JJJose Luis Paz Jara
Jose Luis Paz Jara
MEMarcos N. Eberlin
Marcos N. Eberlin

1 September 2008 in Journal of Biological Chemistry
Verified
Journal Article
Open access
FCFernanda M. Cunha
Fernanda M. Cunha
DBDenise A. Berti
Denise A. Berti
ZFZulma Ferreira
Zulma Ferreira
CKClécio F. Klitzke
Clécio F. Klitzke
RMRegina P Markus
Regina P Markus
EFEmer Ferro
Emer Ferro
Protein degradation by the ubiquitin proteasome system releases large amounts of oligopeptides within cells. To investigate possible functions for these intracellularly generated oligopeptides, we fused them to a cationic transactivator peptide sequence using reversible disulfide bonds, introduced them into cells, and analyzed their effect on G protein-coupled receptor (GPCR) signal transduction. A mixture containing four of these peptides (20-80 microm) significantly inhibited the increase in the extracellular acidification response triggered by angiotensin II (ang II) in CHO-S cells transfected with the ang II type 1 receptor (AT1R-CHO-S). Subsequently, either alone or in a mixture, these peptides increased luciferase gene transcription in AT1R CHO-S cells stimulated with ang II and in HEK293 cells treated with isoproterenol. These peptides without transactivator failed to affect GPCR cellular responses. All four functional peptides were shown in vitro to competitively inhibit the degradation of a synthetic substrate by thimet oligopeptidase. Overexpression of thimet oligopeptidase in both CHO-S and HEK293 cells was sufficient to reduce luciferase activation triggered by a specific GPCR agonist. Moreover, using individual peptides as baits in affinity columns, several proteins involved in GPCR signaling were identified, including alpha-adaptin A and dynamin 1. These results suggest that before their complete degradation, intracellular peptides similar to those generated by proteasomes can actively affect cell signaling, probably representing additional bioactive molecules within cells.

15 April 2010 in Analytical Chemistry
Verified
Journal Article
Closed access
YCYuri E. Corilo
Yuri E. Corilo
BVBoniek Gontijo Vaz
Boniek Gontijo Vaz
RSRosineide Costa Simas
Rosineide Costa Simas
HNHeliara D. Lopes Nascimento
Heliara D. Lopes Nascimento
CKClécio F. Klitzke
Clécio F. Klitzke
MEMarcos N. Eberlin
Marcos N. Eberlin

1 June 2012 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
GSGustavo M. Silva
Gustavo M. Silva
Luis NettoLuis Netto
Luis Netto
VSVanessa Simões
Vanessa Simões
LSLuiz F.A. Santos
Luiz F.A. Santos
FGFabio C. Gozzo
Fabio C. Gozzo
MDMarilene Demasi
Marilene Demasi
The proteasome is the primary contributor in intracellular proteolysis. Oxidized or unstructured proteins can be degraded via a ubiquitin- and ATP-independent process by the free 20S proteasome (20SPT). The mechanism by which these proteins enter the catalytic chamber is not understood thus far, although the 20SPT gating conformation is considered to be an important barrier to allowing proteins free entrance. We have previously shown that S-glutathiolation of the 20SPT is a post-translational modification affecting the proteasomal activities. Aims: The goal of this work was to investigate the mechanism that regulates 20SPT activity, which includes the identification of the Cys residues prone to S-glutathiolation. Results: Modulation of 20SPT activity by proteasome gating is at least partially due to the S-glutathiolation of specific Cys residues. The gate was open when the 20SPT was S-glutathiolated, whereas following treatment with high concentrations of dithiothreitol, the gate was closed. S-glutathiolated 20SPT was more effective at degrading both oxidized and partially unfolded proteins than its reduced form. Only 2 out of 28 Cys were observed to be S-glutathiolated in the proteasomal α5 subunit of yeast cells grown to the stationary phase in glucose-containing medium. Innovation: We demonstrate a redox post-translational regulatory mechanism controlling 20SPT activity. Conclusion: S-glutathiolation is a post-translational modification that triggers gate opening and thereby activates the proteolytic activities of free 20SPT. This process appears to be an important regulatory mechanism to intensify the removal of oxidized or unstructured proteins in stressful situations by a process independent of ubiquitination and ATP consumption. Antioxid. Redox Signal. 16, 1183–1194.

1 July 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
JGJuliano R. Guerreiro
Juliano R. Guerreiro
CLClaudiana Lameu
Claudiana Lameu
EOEduardo F. Oliveira
Eduardo F. Oliveira
CKClécio F. Klitzke
Clécio F. Klitzke
RMRobson L. Melo
Robson L. Melo
ACAntonio C.M. Camargo
Antonio C.M. Camargo
Bj-BPP-10c is a bioactive proline-rich decapeptide, part of the C-type natriuretic peptide precursor, expressed in the brain and in the venom gland of Bothrops jararaca. We recently showed that Bj-BPP-10c displays a strong, sustained anti-hypertensive effect in spontaneous hypertensive rats (SHR), without causing any effect in normotensive rats, by a pharmacological effect independent of angiotensin-converting enzyme inhibition. Therefore, we hypothesized that another mechanism should be involved in the peptide activity. Here we used affinity chromatography to search for kidney cytosolic proteins with affinity for Bj-BPP-10c and demonstrate that argininosuccinate synthetase (AsS) is the major protein binding to the peptide. More importantly, this interaction activates the catalytic activity of AsS in a dose-de pend ent manner. AsS is recognized as an important player of the citrulline-NO cycle that represents a potential limiting step in NO synthesis. Accordingly, the functional interaction of Bj-BPP-10c and AsS was evidenced by the following effects promoted by the peptide: (i) increase of NO metabolite production in human umbilical vein endothelial cell culture and of arginine in human embryonic kidney cells and (ii) increase of arginine plasma concentration in SHR. Moreover, alpha-methyl-dl-aspartic acid, a specific AsS inhibitor, significantly reduced the anti-hypertensive activity of Bj-BPP-10c in SHR. Taken together, these results suggest that AsS plays a role in the anti-hypertensive action of Bj-BPP-10c. Therefore, we propose the activation of AsS as a new mechanism for the anti-hypertensive effect of Bj-BPP-10c in SHR and AsS as a novel target for the therapy of hypertension-related diseases.

1 May 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
DBDenise A. Berti
Denise A. Berti
CMCain Morano
Cain Morano
LRLilian C. Russo
Lilian C. Russo
Leandro CastroLeandro Castro
Leandro Castro
FCFernanda M. Cunha
Fernanda M. Cunha
LFLloyd D. Fricker
Lloyd D. Fricker
Thimet oligopeptidase (EC 3.4.24.15; EP24.15) is an intracellular enzyme that has been proposed to metabolize peptides within cells, thereby affecting antigen presentation and G protein-coupled receptor signal transduction. However, only a small number of intracellular substrates of EP24.15 have been reported previously. Here we have identified over 100 peptides in human embryonic kidney 293 (HEK293) cells that are derived from intracellular proteins; many but not all of these peptides are substrates or products of EP24.15. First, cellular peptides were extracted from HEK293 cells and incubated in vitro with purified EP24.15. Then the peptides were labeled with isotopic tags and analyzed by mass spectrometry to obtain quantitative data on the extent of cleavage. A related series of experiments tested the effect of overexpression of EP24.15 on the cellular levels of peptides in HEK293 cells. Finally, synthetic peptides that corresponded to 10 of the cellular peptides were incubated with purified EP24.15 in vitro, and the cleavage was monitored by high pressure liquid chromatography and mass spectrometry. Many of the EP24.15 substrates identified by these approaches are 9–11 amino acids in length, supporting the proposal that EP24.15 can function in the degradation of peptides that could be used for antigen presentation. However, EP24.15 also converts some peptides into products that are 8–10 amino acids, thus contributing to the formation of peptides for antigen presentation. In addition, the intracellular peptides described here are potential candidates to regulate protein interactions within cells.